These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26785736)

  • 1. Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart.
    Miyagawa S; Fukushima S; Imanishi Y; Kawamura T; Mochizuki-Oda N; Masuda S; Sawa Y
    Curr Gene Ther; 2016; 16(1):5-13. PubMed ID: 26785736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart.
    Higuchi T; Miyagawa S; Pearson JT; Fukushima S; Saito A; Tsuchimochi H; Sonobe T; Fujii Y; Yagi N; Astolfo A; Shirai M; Sawa Y
    Cell Transplant; 2015; 24(12):2479-89. PubMed ID: 25606821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future prospects for regenerated heart using induced pluripotent stem cells.
    Fujita J; Fukuda K
    J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.
    Kawamura M; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura T; Kuratani T; Daimon T; Shimizu T; Okano T; Sawa Y
    Circulation; 2012 Sep; 126(11 Suppl 1):S29-37. PubMed ID: 22965990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of purified iPSC-derived cardiomyocytes in myocardial infarction.
    Rojas SV; Kensah G; Rotaermel A; Baraki H; Kutschka I; Zweigerdt R; Martin U; Haverich A; Gruh I; Martens A
    PLoS One; 2017; 12(5):e0173222. PubMed ID: 28493867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    Soma Y; Tani H; Morita-Umei Y; Kishino Y; Fukuda K; Tohyama S
    J Mol Cell Cardiol; 2024 Feb; 187():90-100. PubMed ID: 38331557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Building a new strategy for treating heart failure using Induced Pluripotent Stem Cells.
    Miyagawa S; Sawa Y
    J Cardiol; 2018 Dec; 72(6):445-448. PubMed ID: 30172684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
    Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Promise of Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Treat Heart Failure.
    Lancaster JJ; Koevary JW; Chinyere IR; Goldman S
    Circ Heart Fail; 2018 Oct; 11(10):e005425. PubMed ID: 30354396
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytes.
    Yu T; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura M; Kawamura T; Ito E; Kawaguchi N; Sawa Y; Matsuura N
    Circ J; 2013; 77(5):1297-306. PubMed ID: 23392122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes.
    Funakoshi S; Miki K; Takaki T; Okubo C; Hatani T; Chonabayashi K; Nishikawa M; Takei I; Oishi A; Narita M; Hoshijima M; Kimura T; Yamanaka S; Yoshida Y
    Sci Rep; 2016 Jan; 6():19111. PubMed ID: 26743035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model.
    Nakamura Y; Miyagawa S; Yoshida S; Sasawatari S; Toyofuku T; Toda K; Sawa Y
    Sci Rep; 2019 Jul; 9(1):10840. PubMed ID: 31346220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes.
    Tabei R; Kawaguchi S; Kanazawa H; Tohyama S; Hirano A; Handa N; Hishikawa S; Teratani T; Kunita S; Fukuda J; Mugishima Y; Suzuki T; Nakajima K; Seki T; Kishino Y; Okada M; Yamazaki M; Okamoto K; Shimizu H; Kobayashi E; Tabata Y; Fujita J; Fukuda K
    J Heart Lung Transplant; 2019 Feb; 38(2):203-214. PubMed ID: 30691596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias.
    Gnecchi M; Stefanello M; Mura M
    Int J Cardiol; 2017 Jun; 237():49-52. PubMed ID: 28408106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction.
    Zhao X; Chen H; Xiao D; Yang H; Itzhaki I; Qin X; Chour T; Aguirre A; Lehmann K; Kim Y; Shukla P; Holmström A; Zhang JZ; Zhuge Y; Ndoye BC; Zhao M; Neofytou E; Zimmermann WH; Jain M; Wu JC
    Stem Cell Reports; 2018 Feb; 10(2):422-435. PubMed ID: 29398480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Soluble Factors from Human Mesenchymal Stem Cells.
    Yoshida S; Miyagawa S; Fukushima S; Kawamura T; Kashiyama N; Ohashi F; Toyofuku T; Toda K; Sawa Y
    Mol Ther; 2018 Nov; 26(11):2681-2695. PubMed ID: 30217728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin.
    Lewandowski J; Rozwadowska N; Kolanowski TJ; Malcher A; Zimna A; Rugowska A; Fiedorowicz K; Łabędź W; Kubaszewski Ł; Chojnacka K; Bednarek-Rajewska K; Majewski P; Kurpisz M
    Cell Transplant; 2018 Jul; 27(7):1047-1067. PubMed ID: 29947252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.